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Highlights:
 We analysed data for 194 children with bilateral cerebral palsy 
Introduction
Alteration in selective motor control (SMC) forms a key impairment in people with cerebral palsy (CP). This commonly results from the inability to activate muscles without obligatory contractions of other muscles, affecting a person's ability to perform functional tasks. Measures of SMC have been shown to correlate with performance in functional tasks, disability and some parameters of gait [1, 2] .
Development of the Selective Control Assessment of the Lower Extremity (SCALE) [3] has allowed reliable assessment of SMC with an easily implemented tool [4] .
SMC is thought to be related to integrity of the corticospinal tract (CST), which is damaged in children with CP [5] . Input from the CST is also thought to have a role in development of neural networks within the spinal cord [6] , which may have a role in the automatic control of walking. SCALE correlates with ability to perform uncoupled hip and knee movement during the swing phase of gait [7] , and therefore may predict outcomes of hamstring lengthening surgeries in children with CP [8] . This is supported by Rha and colleagues findings that SCALE correlates with knee flexion at initial contact in patients who walk with significant knee flexion [9] .
The effect of SMC on overall gait pattern has yet to be reported to the best of the author's knowledge. This study compares SCALE with Gait Profile Score (GPS) [10] , an index of how different a person's gait is to a typically developing population.
Methods
Patients under 18 years of age with a diagnosis of bilateral CP (without evidence of dystonia or ataxia), who attended our gait analysis unit between April 2013 and December 2015 were identified retrospectively. When a patient had attended for multiple analyses, data from a patients first visit only was included. Patients were excluded if a full assessment of their SMC or gait had not been performed.
Assessment of Selective Motor Control
A passive range of motion examination of each lower limb was conducted prior to assessment of SMC. SCALE was assessed according to Fowler et al [3] by one of 3 assessors. SCALE assesses 5 sets of movements on both the left and right lower limbs: hip flexion/extension, knee flexion/extension, ankle dorsiflexion/plantarflexion, inversion/eversion of the subtalar joint and toe flexion/extension. Each set of movements is graded as 0, 1 or 2. Scores for each joint are summed giving a total score with a maximum of 20.
Assessment of gait impairment
GPS was calculated using kinematic data collected as part of routine gait analysis, captured using a VICON camera system (Vicon, Oxford, UK) with a modified Helen Hayes marker set.
Joint centres were estimated from a static trial using the PluginGait lower body model implemented in Vicon Nexus (Vicon, Oxford, UK). Dynamic trials were processed using the PluginGait lower body model, with gait cycle events manually identified and correction of thigh marker position where required [11] . Up to 5 barefoot walking trials were processed, with fewer trials used if the patient was unable to complete 5 trials, due to reasons such as fatigue or pain.
Trials were analysed using Matlab (Matlab release 2015b, The MathWorks, Massachusetts, United States). GPS was calculated according to the description by Baker et al [10] , including the left and right lower limbs. GPS was calculated for each trial and the mean GPS for each patient calculated. The reference GPS has been calculated from historical data from 30 typically developing children (8 males, 22 females), with a mean age of 10 years (sd = 2.1). This data was collected at the same laboratory using the same protocols as data collected for patients used in this study.
For each patient, a contemporaneous description of general level of mobility was reported. This was used to assign each patient a GMFCS level [12] .
As SCALE gives an ordinal scoring, non-parametric statistical tests were used. A Kruskal-Wallis Test was used to assess for significant difference in the distributions of total SCALE score for each GMFCS level. The SCALE scores and mean GPS for each patient were compared, using a Spearman's rank-order correlation, with significance accepted at p < 0.05 for all tests.
Results
Two hundred and nine patients with bilateral CP were identified. Fourteen assessments were excluded as complete sets of SCALE data had not been collected due to lack of compliance. Of the 195 remaining assessments, 194 included valid gait data, as one patient (GMFCS IV) was not able to complete walking trials. See Table 1 for group characteristics.
Distributions of total SCALE score were significantly different between GMFCS levels, X 2 (2) = 76, p< 0.001, see Figure 1 . Post-hoc analysis revealed significant differences in SCALE scores between GMFCS I (mean rank = 158) and II (mean rank = 113), (p = 0.009), GMFCS II and III (mean rank = 40), (p< 0.001) and GMFCS I and III (p< 0.001).
Preliminary analysis of the relationship between GPS and SCALE scores showed the relationship to be monotonic, as assessed by visual inspection of a scatterplot.
There was a significant negative correlation between total SCALE and GPS, rs = -0.603, p< 0.001, see Figure 2 .
Discussion
In addition to previously reported results demonstrating a relationship between SCALE and specific gait parameters [7, 9] , these results demonstrate a correlation between SCALE and overall gait abnormality.. SCALE is a measure of SMC, which is thought to be related to integrity of the CST [13] . The role of the CST is yet to be fully understood and is thought to be central in the modulation of afferent input to the spinal cord, the development of interneuronal networks and the lowering of thresholds of alpha motor unit modulation [6] .
Damage to the CST may explain many of the impairments observed in CP such as weakness, lack of reciprocal inhibition and hyperreflexia. Consequently, a measure of SMC, such as SCALE, should be strongly associated with GMFCS and to gait abnormality. Balzer et al demonstrated a significant difference between SCALE scores for children with GMFCS levels I and II, but were unable to show a significant difference between SCALE scores for GMFCS levels II and III [4] . Data included in this study demonstrated a significant difference between each GMFCS level I-III in SCALE scores, see Figure 2 , likely due to a larger sample size. When just those with a GMFCS level of III are included, the strength of the correlation between SCALE and GPS is reduced (see Supplementary Material).
Individuals with CP demonstrate less complexity in their control strategies during gait than their typically developing peers and appear to demonstrate strategies similar to the rhythmic stepping observed in infants [14, 15] . This lack of development of mature control strategies may be the underlying mechanism resulting in both impairments in SMC and impairments observed in gait. Assessing both SMC and gait abnormality may therefore provide an insight into the underlying neurological causes of both.
Limitations
This study was limited to ambulant children attending for gait analysis and therefore was unable to assess GMFCS levels IV and V. A supplementary analysis demonstrated that when SCALE and an index of key clinical examination measures are used to predict GPS, SCALE accounts for far more of the variation in GPS (see Supplementary Material).
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